Companies Cryptocurrencies
Twist Bioscience Corp
Twist Bioscience Corp
Exchange: NasdaqGS
IPO Date: 31/10/2018
CEO: Ms. Emily Leproust
Diagnostics & Research Healthcare 🔗
  • TWST
  • 35.3
  • 1986119168
    market cap
  • -2.1500015
If you bought

shares of Twist Bioscience Corp (TWST) on
You would have made
Old Price $12 Current Price $12

Twist Bioscience Corp. develops proprietary semiconductor-based synthetic DNA manufacturing process. The company is headquartered in South San Francisco, California and currently employs 414 full-time employees. The firm is developing a disruptive deoxyribonucleic acid (DNA) synthesis platform to industrialize the engineering of biology. The firm has a semiconductor-based synthetic DNA manufacturing process featuring 10,000-well silicon platform, which is capable of producing synthetic biology tools, such as genes, oligonucleotide pools and variant libraries. Its silicon-based DNA writing platform offers synthesis of genes on silicon. Its products include clonal perfect genes and non-clonal fragments. The company offers protein scanning single variant libraries. Its design methodology, coupled with its silicon-based synthesis platform, enables synthesis of each library variant positioned exactly where user wants it to be. The company offers unamplified oligo pools and cloning-ready oligo pools. Its platform offers synthesis of oligonucleotide pools for specific targeting.

Address: 681 GATEWAY BLVD. South San Francisco CALIFORNIA 94080

Stay updated.